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Abstract
Targeted lymphatic delivery of nanoparticles for drug delivery and imaging is primarily dependent 
on size and charge. Prior studies have observed increased lymphatic uptake and retentions of over 
48 hrs for negatively charged particles compared to neutral and positively charged particles. We 
have developed new polymeric materials that extend retention over a more pharmaceutically 
relevant 7-day period. We used whole body fluorescence imaging to observe in mice the 
lymphatic trafficking of a series of anionic star poly-(6-O-methacryloyl-D-galactose) polymer-
NIR dye (IR820) conjugates. The anionic charge of polymers was increased by modifying 
galactose moieties in the star polymers with succinic anhydride. Increasing anionic nature was 
associated with enhanced lymphatic uptake up to a zeta potential of ca. -40 mV; further negative 
charge did not affect lymphatic uptake. Compared to the 20% acid-conjugate, the 40 to 90% acid-
star-polymer conjugates exhibited a 2.5- to 3.5-fold increase in lymphatic uptake in both the 
popliteal and iliac nodes. The polymer conjugates exhibited node half-lives of 2 to 20 hrs in the 
popliteal nodes and 19 to 114 hrs in the deeper iliac nodes. These polymer conjugates can deliver 
drugs or imaging agents with rapid lymphatic uptake and prolonged deep-nodal retention; thus 
they may provide a useful vehicle for sustained intralymphatic drug delivery with low toxicity.
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1. Introduction
The uptake and distribution of nanoparticles in the lymphatic system is dependent on the 
size, charge, hydrophobicity, injection site, and the dose of the nanoparticles (Hawley et al., 
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1995; Porter, 1997; Rao et al., 2010). A number of different delivery vehicles have been 
employed for lymphatic imaging and drug delivery, including: liposomes, dendrimers, 
quantum dots, synthetic polymers, and natural polymers. Our laboratory has previously 
investigated a natural biopolymer, hyaluronan (HA), for targeted lymphatic drug delivery 
(Cai et al., 2010a; Cai et al., 2008; Cai et al., 2010b, c; Cohen et al., 2009) and determined 
the optimal particulate size for lymphatic uptake and nodal retention to be 30-50 nm by 
utilizing in vivo fluorescence imaging and fluorophore-labeled polymers.
The effects of size on lymphatic uptake have been well described (Rao et al., 2010), but 
charge also is an important factor in lymphatic uptake. Negatively charged proteins, 
liposomes, dendrimers, and PLGA-nanospheres have increased lymphatic uptake compared 
to neutral to positively charged particles (Kaminskas and Porter, 2011; Patel et al., 1984; 
Rao et al., 2010; Takakura et al., 1987; Takakura et al., 1992); This is due in part to the 
electrostatic repulsions between the negatively charged particles and the extracellular matrix 
(Rao et al., 2010), which is primarily negatively charged (Hawley et al., 1995; Porter, 1997; 
Rao et al., 2010). Also, negatively charged particles are retained longer and to a greater 
extent by lymph nodes (Kaminskas and Porter, 2011; Patel et al., 1984). However, these 
studies examined chemically dissimilar particles or proteins, and only one study to date has 
examined the effect of varying negative charge on lymphatic uptake of otherwise similar 
particles. Rao and coworkers adjusted the ratio of carboxylic acid terminated poly(D,L-
lactic-co-glycolic) in PLGA nanoparticles, and they found that increased negative charged 
resulted in increased lymphatic uptake during the first 48 hrs in rats (Rao et al., 2010).
Liposomes, dendrimers, PLGA nanoparticles, and micelles are the most commonly used 
platforms for lymphatic delivery, and all can be modified with a polyanionic surface to 
optimize lymphatic uptake. With the exception of PLGA nanoparticles, the uptake of these 
particles has not been optimized. Also, these technologies are not appropriate for many drug 
delivery tasks. For example, dendrimers have limited drug capacity and may not be 
biodegradable. Liposomes and micelles can be destabilized in the extravascular space 
(Proulx et al., 2010). PLGA nanoparticles can be difficult to manufacture and may not be 
sustain the release of small molecule drugs. For these reasons, we developed a new water 
soluble and degradable star polymer as a lymphatic delivery platform with controlled 
degrees of anionic charge (Duan et al., 2012). Star polymers are three-dimensional with 
linear polymeric arms emanating from a branched central core (Cameron and Shaver, 2010; 
Mendrek and Trzebicka, 2009). Like dendrimers, star polymers are branched polymers that 
have a compact structure, are globular in shape, and have large surface areas, which make 
them optimal platforms for lymphatic delivery. Further, hyperbranched polymers and multi-
arm star polymers exhibit low intrinsic viscosities and increased solubilities compared to 
their linear counterparts (Chen et al., 2006; Hult et al., 1999). Star polymers can be 
synthesized using living radical polymerization techniques to accurately control the 
molecular weight (Boyer et al., 2009; Gregory and Stenzel, 2011).
A series of 4-armed star-polymers with controlled degrees of negative charge were 
developed determine the effect of anionic character on lymphatic uptake. A near infrared 
dye, IR820, was conjugated to the polymers, so the effects of charge on lymphatic uptake 
and retention could be measured non-invasively by whole body fluorescent imaging in mice.
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2.1 Materials and Methods
Unless noted otherwise, all reagents were ACS grade or better and were purchased from 
Sigma Aldrich Chemical Co. (St. Louis, MO, USA) or Thermo Fisher Scientific (Waltham, 
MA, USA). Deuterated solvents for NMR analysis were purchased from Cambridge Isotope 
Laboratories (Andover, MA, USA). 1H-NMR (400 MHz) and 13C-NMR (100 MHz) spectra 
were collected on a Bruker DRX 400 spectrometer. Chemical shifts were referenced to δ7.28 
and 77.0 ppm for 1H-NMR and 13C-NMR spectra, respectively. Cell culture media was 
purchased from Fisher Scientific (Pittsburgh, PA) or ATCC (Manassas, VA, USA). 
Polyethylene glycol and polystyrene standards were obtained from Scientific Polymer 
Products (Ontario, NY, USA).
2.2 Star Polymer Synthesis (Star 3)
A series of 4-arm star polymers with controlled degrees of anionic charge, were previously 
synthesized in our laboratory using the MADIX/RAFT polymerization method. The detailed 
procedure of the star polymer synthesis and the 1H NMR assignments is reported elsewhere 
(Duan et al., 2012). Figure 1A depicts the simplified reaction scheme for the star polymer 
used herein. The MADIX agent was synthesized using the methods reported by Stenzel et al. 
(Stenzel et al., 2004). The MADIX agent was formed by the addition of a xanthate group to 
pentaerythritol to form the 4-armed core 1 for the star polymer. The MADIX/RAFT 
polymerization were carried out according to the procedures of Ting et al (Ting et al., 2009). 
A 6-O-methacryloyl-D-galactose was used as the repeating unit in the polymerization 
reaction initiated by AIBN to give the sugar-star polymer. After deprotection, the sugar-star 
polymer 2 (Star 2) was modified with various amounts of succinic anhydride to vary the 
degree of anionic charge on the star polymer. Typically, 20, 40, 60, and 90 wt% succinic 
anhydride was mixed with the sugar-star polymer 2 in DMF/pyridine to yield the sugar-acid 
star polymers 3 with 20, 40, 60, and 90 wt% acid (Star 3-20, Star 3-40, Star 3-60, and Star 
3-90), respectively. Structures of the synthesized compounds were verified by 1H-NMR.
The molecular weights and polydispersity index (PDI) of the protected star polymer, poly-
(1,2:3,4-Di-O-isopropylidene-6-O-methacryloyl-α-D-galactopyranose), and deprotected star 
polymer, poly-(6-O-methacryloyl-D-galactose) 2, were determined by size exclusion 
chromatography (SEC) (Shimadzu 2010CHT) using a TSK gel multipore Hx-M column 
coupled with a refractive index detector (Shimadzu RID-10A), and using 0.8 ml/min of 
DMF containing 10-mM LiCl as the mobile phase. Calibration curves were generated with 
polystyrene standards (1,180 to 339,500 g/mol) or polyethylene glycol (PEG) standards 
(3070 to 66,100 g/mol) for the protected and deprotected sugar-star polymers, respectively.
2.3 Star-IR820 Synthesis (Star 5)
The dye IR-820 was conjugated to the star polymers for in vivo imaging (Figure 1B). First, 
to a solution of IR-820 (100 mg, 0.094 mmol) in 20 ml of dry DMF, 1,3-diaminopropane 
(40 μL, 0.47 mmol) was added dropwise. The solution was gradually heated to 60 °C and 
stirred for 4 h protected from light. The solvent was removed under reduced pressure, and 
the produced was purified by column chromatography (1:1 EtOAC:MeOH). The combined 
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fractions were dried under reduced pressure to yield a dark blue solid 4 (65 mg, 78% yield). 
The 3-aminopropyl-amino-IR820 4 was conjugated to the sugar-acid star polymer 3 in dry 
DMF with EDAC activation and HOBt·H2O as the catalyst. A cooled solution (0 °C) of the 
sugar-acid-star polymer 3 (60% acid) (75 mg) in 20 ml dry DMF, EDAC (28.1 mg, 0.147 
mmol) and HOBt·H2O (22.5 mg, 0.147 mmol) were combined. After five minutes, 4 (65 
mg, 0.073 mmol) in DMF (5 ml) was added dropwise. The reaction proceeded at ambient 
temperature overnight and protected from light. The resulting sugar-acid-star-polymer-
IR820 5 (star 5) was purified by dialysis (10,000 MWCO, Pierce, Rockford, IL, USA) 
against EtOH:H2O (1:1) followed by 100% EtOH. Concentration under reduced pressure 
resulted in a bluish-purple solid. The loading degrees of IR820 on the series of star polymers 
were determined by 1H NMR in MeOD.
2.4 Rheological Properties
The viscosities of the acid star polymers were determined in PBS at pH 7.4. Samples of 
sugar star polymer (compound 2) and sugar acid star polymer (compound 3) were dissolved 
in PBS (at ca. 100 mg/ml conc.) and dialyzed against PBS (pH 7.4) for 48 h at ambient 
temperature using a 3.5-kD MWCO dialysis tubing (regenerated cellulose, Fisherbrand) to 
adjust the pH. The star polymers were then diluted to 1, 5, and 10 mg/ml with PBS (pH 7.4), 
and the rheological properties were measured in triplicate using an Advanced Rheometer 
2000 (TA Instruments, New Castle, DE) at 25°C using a 40-mm 2° aluminum cone 
geometry and a 49-μm gap distance. The shear rate was increased using a steady-state flow 
step from 10 to 100 s−1 using 10 points per decade on a log scale and sample periods of 10 s. 
The steady state parameters were set to 5% deviation for three consecutive points within a 
maximum time of 1 minute per shear rate.
2.5 Zeta Potential of the Star Polymers
Star 2 and Star 3 (-20, -40, -60, and -90) polymer (compounds 2 and 3) samples were 
dissolved in ddH2O at a concentration of ca. 1 mg/ml, the pH then was adjusted to 7.2 ± 0.1 
with 1-N sodium hydroxide, and the final concentration was noted. The samples were 
diluted to 100 μg/ml with pH 7.25 1-mM phosphate buffer and 1 mM of KCl, and the pH 
was readjusted if necessary. Zeta potentials were measured on a ZetaPALS (Brookhaven 
Instruments Corporation, Holtsville, NY, USA) at 20°C, and the sample measurements were 
repeated six times. The statistical analysis of the zeta potentials of the star 2 and star 3 
polymers was evaluated using a student t-test (GraphPad Prism 4).
2.6 Size Distribution Measurement
Sugar multi-arm polymer and its acid-modified derivatives from 20% wt/wt to 90% wt/wt 
were prepared at 0.2 mg/mL in double distilled water. Polymer solutions were filtered 
through 0.2-μm syringe filters before hydrodynamic radius measurements. The 
hydrodynamic radius of each sample was determined using a DynaPro™ Plate Reader 
(Wyatt Technology, Santa Barbara, CA, USA) for five acquisitions, and for each acquisition 
the sample was scanned for twenty times.
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2.7 In vitro Toxicity of the Star Polymers
The cancer cell lines B16F10 (lymphatically metastatic murine melanoma, ATCC, 
Manassas, VA, USA), MDA-MB-231 (human breast cancer), MDA-1986 (human head and 
neck squamous cell carcinoma), and HUVEC (normal human endothelial) cell lines, were 
maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1% L-
Glutamine and 10% bovine growth serum in 5% CO2 atmosphere. The HER2 expressing 
murine breast cancer cell line, 4T1.2 Neu, was a gift from Dr. Zhaoyang You of the 
University of Pittsburg, and the cells were maintained in DMEM supplemented with 1% L-
Glutamine, 10 % bovine growth serum, and 500 μg/ml of G418 (geneticin) in a 5% CO2 
atmosphere. The lymphatically metastatic human melanoma cell line, A2058, was purchased 
from ATCC and was maintained in low sodium bicarbonate DMEM (ATCC) supplemented 
with 1% L-Glutamine and 10% bovine growth serum in a 5% CO2 atmosphere.
The sugar-acid star polymer (compound 3) samples (20, 40, 60, and 90 wt% succination) 
were dialyzed against PBS (as described in rheometry section) for 48 h to adjust the pH to 
7.4. The solutions were concentrated to ca. 100 mg/ml using a Speedvac concentrator 
(Labconoco) and diluted in sterile 1× PBS (Fisher BioReagents, pH 7.4) to eight 
concentrations between 10−4 and 10−9 M. Prior to cell growth inhibition studies, cells were 
trypsinized and seeded at 3000 cells/well in 96-well tissue culture treated plates. After 24 h, 
the Star 3-20, Star 3-40, Star 3-60, and Star 3-90 acid-sugar star polymers (compound 3) in 
PBS were added to the HUVEC, A2058, and 4T1.2 Neu cells (n=8, 10 μL/well, 8 
concentrations). The Star 3-60 sample was further tested in the B16F10, MDA-MB-231, and 
MDA-1986 cells. A solution of 10% trichloracetic acid was used as a negative control, and 
media was used as a positive control (n=8, 10 μL/well). At 72 h post addition, 10 μL of 
resazurin blue in PBS was added (5-μM final concentration) to each well and the well 
fluorescence was measured after 3 h ( λex/λem = 560/590 nm) (SpectraMax Gemini, 
Molecular Devices, Sunnyvale, CA, USA). IC50's were determined using the nonlinear 
regression curve fit for a one-site competition (GraphPad Prism 4, GraphPad Software, La 
Jolla, CA, USA).
2.8 In vivo Imaging of Star-IR820 (Star 5)
Animals were maintained in sterile housing under the veterinary supervision of the 
University of Kansas Animal Care Unit. All procedures were approved by the Institutional 
Animal Care and Use Committee. All mice were fed a low chlorophyll diet (Harlan 2918 
irradiated diet, Harlan Laboratories, Indianapolis, IN, USA) for at least one week prior to 
imaging to decrease food induced organ and skin autofluorescence. The mouse's hair in the 
area of interest for imaging was removed 24 h prior to imaging with clippers followed by 
depilatory cream. Female Balb/c mice (20-25 g, Charles River) (3 per group) were 
anesthetized under isoflurane, placed on a heating pad to maintain normal body temperature, 
and were injected subcutaneously (s.c.) with 10 μL of a filter-sterilized 0.1-mg/ml (IR820 
dye conc.) solution of star 5 conjugates (20%, 40%, 60%, or 90% acid substitution) in the 
center of the right hind footpad. The mice were imaged from both the dorsal and right sides, 
both with and without the injection site being covered, for a maximum of 7 days using 
whole body fluorescence imaging (Cambridge Research and Instrumentation MaestroFlex, 
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Woburn, MA) using an excitation filter of 710-760 nm and broadpass emission filter of 
800-950 nm. Animals were not imaged for more than 5 minutes during any single session.
The intense fluorescence signal from the injection site could saturate the camera, especially 
during early time points, so it was covered with black tape to improve the dynamic imaging 
range for the draining lymphatic vessels and lymph nodes. Images were acquired using the 
autoexposure function, which limits the pixel saturation to <2%, and exposure times were 
recorded. The use of the autoexposure function resulted in different exposure times for each 
image, which were normalized by dividing the total counts by the exposure time. The f-stop, 
camera position, and zoom setting were held constant throughout the studies.
2.9 In vivo Imaging Data Analysis
Images were analyzed using the Maestro software (ver. 2.10). Regions of interest (ROI) 
were placed over the popliteal and iliac lymph nodes. The total signal (scaled counts/s, see 
equation below) was recorded for each ROI from both positions (prone and right), and the 
signal was graphed versus time. In addition, the area under the curve (AUC) was determined 
from the total fluorescence intensity versus time graphs. Significance between multiple 
groups was determined by one-way ANOVA analysis with a Tukey Multiple Comparisons 
post-test and student t-tests (GraphPad Prism 4).
3. Results
3.1 Characterization of the Star Polymer and Star-IR820 Conjugates
The synthesis of sugar-star polymers (compound 2) was verified by mass spectroscopy and 
NMR (data not shown) (Duan et al., 2012). The molecular weight and PDI were determined 
by SEC to be 75,000 and 1.132, respectively for the protected sugar-star polymer (reaction 
intermediate), and 45,000 and 1.15 for the deprotected sugar-star polymer (compound 2). 
The IR820 loading degree was determined by 1H NMR in MeOD using the ratio of the 
aromatic protons of IR820 with the proton on the repeating unit of the star-polymer. The 
calculated molecular weights and the IR820 loading degrees are presented in Table 1.
3.2 Rheological Properties
The effects of size and charge on the rheological properties of the star polymers were 
determined. The viscosities of the star polymer samples in Figure 2 represent the apparent 
viscosities of the polymers at a shear rate of 100 s−1, although the star polymer did appear to 
undergo minimal shear thinning over the shear rates examined. As the concentration of star 
polymer was increased the apparent viscosity also increased. However, as the molecular 
weight increased (Star 2 < Star 3-20 < Star 3-40 < Star 3-60 < Star 3-90) at a given 
concentration, the apparent viscosity remained relatively constant (Figure 2).
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3.3 Zeta Potential of the Star Polymers
The zeta potential increased linearly with an increase in wt% substitution of acid on the star 
polymers (R2 = 0.983) (Figure 3). The zeta potentials of the star polymer samples were 
determined at pH 7.4 to ensure that all of the carboxylic acid functional groups were fully 
ionized (pKa ca. 4-5), which minimizes effects due to partial protonation of the carboxylic 
acids. Partial protonation would lead to a reduction in the double layer thickness and zeta 
potentials of lower magnitude than for fully ionized polymers. Further, the pH studied is 
indicative of the ionization state in vivo, thus the zeta potentials are relevant for the 
nanoparticles under in vivo conditions. The difference in zeta potentials for the star polymers 
(Star 2 and Star 3 polymers) were statistically significant with p<0.05 for all pairs of 
polymers, with the exception of the Star 2 (0% acid) vs. Star 3-20 and Star 3-40 vs. Star 
3-60, which were not statistically significant.
3.4 Size Distribution Measurement
The hydrodynamic radii and polydispersities of the sugar star polymers were reported in 
Table 2. The average diameters of all polymeric nanocarriers ranged approximately from 25 
to 50 nm, which meets the size requirement for particle lymphatic uptake.
3.5 In vitro Toxicity of the Star Polymers
All four of the sugar-acid star polymers (Star 3-20, Star 3-40, Star 3-60, and Star 3-90) 
(compounds 3) had similar low anti-proliferative activity in the cell lines examined 
including normal and cancer cell lines, with the exception of the Star 3-60 60% acid sugar 
star polymer in the MDA-1986 cancer cells. In this case, the star polymer was 10-fold more 
cytotoxic in MDA-1986 than other lines (Table 3).
3.6 In vivo Imaging of Star-IR820
In this study, the four star-5 conjugates have identical chemical backbones and a relatively 
narrow size range, 55 and 85 kDa, but have zeta potentials over a wide range of -28 to -68 
mV. The differences in the lymphatic uptake of the star polymers after s.c. administration 
are expected to be governed primarily by charge rather than size. Drainage from the 
injection site occurs at similar rates for all four of the star 5 conjugates, as indicated by the 
same tmax (time to reach maximal fluorescence signal) of 0.75 to 0.83 hr (Table 4). In 
another study by our laboratory with a series of different MW hyaluronan polymers (6.4 kD 
to 697 kD) with the same charge, the tmax increased with polymer MW (unpublished data).
The drainage kinetics to the popliteal and iliac nodes of the Star 5 conjugates post s.c. 
administration are presented in Figures 4 A and B, respectively (Figure 5). The kinetic 
profile for the lymphatic drainage of the Star 5-20 conjugate to both the popliteal and iliac 
nodes indicates that the Star 5-20 conjugate has statistically lower lymphatic uptake and 
increased retention in the popliteal and iliac lymph nodes over the length of the study 
compared to the Star 5-40, Star 5-60 and Star 5-90 acid-star-IR820 conjugates (popliteal 
node, p<0.05, <0.0001, and <0.001, for the Star 5-40, Star 5-60 and Star 5-90, respectively; 
iliac node, p<0.0001 for all three conjugates). The Star 5-20 conjugate is highly retained at 
the injection site and the popliteal node, as indicated by the lower maximum fluorescence 
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signal and longer t50% (time required for the fluorescence signal to reduce by 50%) (Table 4 
and Figure 4A).
Over the first 24 and 6 h, the kinetic profiles for the lymphatic drainage to the popliteal node 
of the Star 5-40 and Star 5-90 conjugates were significantly different than that of the Star 
5-60 conjugate (p<0.05), as indicated by its significantly shorter t50% (Figure 4A and Table 
4). Whereas, the Star 5-40 and Star 5-90 conjugates did not exhibit any significant 
differences in their lymphatic uptake to the popliteal node, which both have similar t50% 
values (Figure 4A and Table 4). The kinetic profiles for the lymphatic uptake to the iliac 
node revealed slightly different trends compared to the popliteal node. The Star 5-90 
conjugate profile was statistically different than the Star 5-40 and Star 5-60 conjugates over 
the first 24 and 50 h, respectively (p<0.05), in that the Star 5-90 conjugate exhibited the 
shortest tmax and a longer t50% than for the Star 5-40 and Star 5-60 conjugates which had 
similar t50% and tmax values Figure 4B and Table 4).
The Star 5-40, Star 5-60 and Star 5-90 acid-star-IR820 conjugates exhibit remarkably 
different nodal retentions in the popliteal and iliac lymph nodes. The Star 5-60 conjugate 
cleared rapidly from the popliteal node compared to the other conjugates as indicated by the 
short t50% (p<0.05, Table 4), but was retained in the iliac node for almost a day. In contrast, 
the Star 5-40 and star 5-90 conjugates have similar popliteal t50% values of ca. 4 h 
(p<0.001), but the Star 5-90 conjugate was retained two times longer in the iliac node in 
comparison with Star 5-40 and Star 5-60 conjugates (Table 4). Further, the Star 5-20 
conjugate was highly retained in both the popliteal and iliac nodes compared to its more 
anionic counterparts as demonstrated by its longer t50% values (p<0.05). However, the 
distribution of the AUC for the different degrees of anionic charge was similar for both the 
popliteal and iliac nodes (Figures 4C and D). The Star 5-40, Star 5-60, and Star 5-90 
conjugates exhibited a 2.5- to 3.5-fold increase in the lymphatic uptake compared to the Star 
5-20 conjugate for both the popliteal and iliac nodes (p<0.05, student t-test, star 5-20 vs star 
5-40 (popliteal), star 5-60 (popliteal and iliac), and star 5-90 (popliteal)).
We imaged mice from both right and dorsal sides to assess drainage into the popliteal and 
iliac nodes. The same trends were observed for both imaging positions, but the right side 
was used for analysis as it produced greater signal intensities and a higher signal to noise 
ratio compared to the dorsal or ventral positions. The ventral position resulted in a decrease 
in the signal to noise ratio due to the increased autofluorescence contributions of the organs 
in the abdomen. In addition, the iliac node was not visualized while imaging in the ventral 
position due to its increased depth in this position. Both the lymph nodes and draining 
lymphatic vessels were clearly visualized against the background tissues using fluorescence 
imaging (Figure 5). Due to limitations of in vivo fluorescence imaging, only shallow nodes 
were identified; further drainage past the iliac node of these Star 5 conjugates is possible.
4. Discussion
Compared to linear polymers, star polymers are better optimized for lymphatic imaging and 
drug delivery due to their inherent low viscosities, increased solubility, decreased solution 
entanglement, and enhanced thermodynamic properties (Cameron and Shaver, 2010; Hult et 
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al., 1999; Qiu and Bae, 2006). Within the concentration range appropriate for drug delivery, 
the apparent viscosities of the star polymer were virtually independent of increases in drug 
concentration and molecular weight. Compared to the viscosity of water, which is 0.001 
Pa·s, at 20°C, the observed viscosities of the star polymers were ca. 0.001 to 0.0012 Pa· s, 
which are insignificant differences in viscosity in practice.
In addition to size, particle charge plays a critical role in lymphatic uptake, retention, and 
disposition (Patel et al., 1984; Rao et al., 2010; Takakura et al., 1987; Takakura et al., 1992). 
After subcutaneous administration of negatively charged particles, they are readily drained 
into lymphatics from the interstitium due to the electrostatic repulsions between the 
negatively charged particles and the extracellular space (Rao et al., 2010). Conversely 
positively charged particles drain more slowly from the injection site due to the attractive 
forces between the particles and the negatively charged matrix. Zeta potential (ζ) can be 
used to measure the ionic nature of nanoparticles zeta potential greater than 30 mV indicates 
a strongly cationic particle, between +10 and −10 mV is considered to be a neutral particle, 
and less than -30 mV indicates a strongly anionic particle (Clogston and Patri, 2011).
The correlation between star polymer zeta potential and percent substitution of succinic 
anhydride allows for comparisons of the lymphatic uptake of the acid-star polymers with 
other polymeric systems. Rao et al. developed a series of PLGAPMA:PLGA-COOH 
nanoparticles with an increasing ratio of PLGA-COOH to PLGAPMA to increase the 
anionic character, resulting in an increase in zeta potential from - 44.6 ± 11.3 mV to -57.1 ± 
11.1 mV (an increase of their absolute values). As the zeta potential increased, an increase in 
the lymphatic uptake was observed. A 4.7-fold increase in the nanoparticle concentration in 
the popliteal node and a 10.1-fold increase in the cumulative nodal uptake (combination of 
the popliteal, internal inguinal, iliac, and renal lymph nodes) were observed for the -57.1 
mV (20:80 PLGA-PMA:PLGA-COOH) nanoparticles.
Intralymphatic drug delivery vehicles should be optimized not only for size, but also for 
charge to speed lymphatic uptake and enhance nodal retention after subcutaneous 
administration. Cationic particles show slowest injection site drainage after s.c. injection, are 
poorly retained by the lymph nodes, have increased toxicity, liver accumulation, and have a 
high propensity for macrophages engulfment (Hawley et al., 1997; Jain et al., 2010; 
McNerny et al., 2010; Patel et al., 1984; Takakura et al., 1992). In contrast negatively 
charged particles exhibit enhanced lymphatic uptake, increased nodal retention, and 
decreased toxicity.
Toxicity both in vitro and in vivo is highly important in developing synthetic polymers for 
enhanced lymph node retention. Cationic dendrimers exert their toxicity by interacting with 
the negatively charged lipid bilayer, resulting in destabilization of the cellular membrane 
(Jain et al., 2010; McNerny et al., 2010). The star polymers do not exhibit significant 
toxicity in vitro when compared to similar poly-ionic polymers currently used for drug and 
gene delivery (IC50 ca. 5 mg/ml). For example, the Star polymers 3 are 100-fold less toxic 
than most cationic dendrimers and PEI used for drug and gene delivery. Peng et al. 
demonstrated that chlorin-core star block m-PEG-b-PCL copolymer micelles exhibited no 
observable toxicity against MCF-7 breast cancer cells after 24 h incubation at the highest 
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concentration of 500 μM (Peng et al., 2008), which is similar to our star polymers (IC50 ca. 
50 to 100 μM).
While the Star 5-40, Star 5-60, and Star 5-90 polymers all exhibit similar cumulative 
lymphatic uptake, the Star 5-60 conjugate had more favorable characteristics of rapid 
drainage from the popliteal lymph node coupled with long retention in the iliac node. The 
sugar moiety in the repeating unit of the star polymer was included primary to enhance 
solubility, and the addition of saccharides to liposomes has been reported to enhance 
lymphatic uptake and nodal retention (Wu et al., 1981). The sugars also substantially 
decreased the toxicity of these polymers and enhanced biocompatibility. Similar acid star 
polymers made without the sugar moiety (data not shown) were considerably more toxic in 
vitro and in vivo.
The star polymers did not exert any visible signs of toxicity or adverse effects over the 7 day 
kinetic study at concentrations as high as 0.7-mg/kg Star 5 conjugate. In addition, study 
animals have been monitored for up to 6 months after injection with no visual indication of 
poor health or reduction in normal growth rate. Nano-sized particles can exert considerable 
chronic toxicity with no acute in vivo or in vitro toxicity. Chen et al. reported that gold 
nanoparticles less than 5 nm and greater than 50 nm were non-toxic after intraperitoneal 
injection; however, particles of 8 to 37 nm caused death within 3 weeks (Chen et al., 2009). 
The study concluded the toxicity was due to nonimmunogenicity of the particles, and the 
addition of immunogenic peptides made the nanoparticles tolerable. The star polymers were 
given subcutaneously, which may substantially increase the exposure to the immune 
surveyance system due to preferential accumulation in the lymph nodes. In addition, the star 
polymers incorporate biodegradable ester linkages in the arms, which may improve 
clearance of the material as the arms disconnect from the core.
5. Conclusions
We developed a new star-polymer with controlled degrees of anionic charge for lymphatic 
imaging and drug delivery. The star-polymer platform displays similar characteristics to 
dendrimers, but its synthesis is more straightforward and cost effective. In addition, this 
platform exhibited significantly reduced toxicities compared to conventional dendrimers 
such as PAMAM. Star polymers exhibit similar lymphatic uptake and trafficking 
characteristics to endogenous polysaccharide, such as HA, but are significantly less viscous 
and easily functionalized with drug or dyes. Further, the star polymer platform provides a 
compact, low polydispersity carrier with numerous functional groups for conjugation. 
Finally, we were able to optimize for rapid lymphatic uptake and prolonged deep-nodal 
retention.
The star polymers were highly retained within the iliac node compared to the popliteal node, 
suggesting that the star polymer platform may be beneficial for treatment of the deep 
lymphatics where metastases in the echelon nodes are present. The star polymers could be 
used as treatment carriers for locally advanced metastatic cancers with the involvement of 
two or more lymph nodes. The rapid drainage of the Star 5-40, Star 5-60, and Star 5-90 
polymer conjugates could minimize the local release of chemotherapeutics at the injection 
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site due to their rapid drainage from the injection site and enhanced lymphatic uptake 
relative to the Star 5-20 polymer. Additionally, the acid-star polymers 3 would be ideal 
carriers for vesicating drug conjugates, since the carriers are rapidly trafficked from the 
injection site to the deeper lymph nodes. Currently, we are developing anti-cancer drug 
conjugates of the star polymers for the treatment of regionally metastatic cancers.
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A) Synthesis of the 4-arm sugar star polymers 2 by MADIX/RAFT polymerization and the 
subsequent modification with succinic anhydride to yield the 20, 40, 60, and 90% wt/wt 
sugar-acid star-polymers 3. B) Conjugation of 3-aminopropyl-amino-IR820 4 to a sugar-
acid-star polymer 3 to yield the star-IR820 conjugate 5.
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Viscosity of the sugar-star polymers in pH 7.4 PBS at a shear rate of 100 s−1. (n=3)
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Zeta potentials of the different wt% acid sugar star polymers at 20 °C, 100 μg/ml, and a 1-
mM phosphate buffer (pH 7.25) with 1-mM KCl. (R2 = 0.983). Where 0, 20, 40, 60 and 90 
% acid correspond to the Star 2, Star 3-20, Star 3-40, Star 3-60, and Star 3-90 polymers, 
respectively
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Star-IR820 (Star 5 conjugates) drainage to the popliteal (A & C) and iliac (B & D) lymph 
nodes. Drainage kinetics to the A) popliteal and B) iliac lymph nodes after s.c. 
administration into the right hind footpad. Area under the curve (AUC) of the acid-star-
IR820 conjugates in the C) popliteal and D) iliac lymph nodes. (AU ≡ Arbitrary Units) (* p 
= 0.0194)
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Representative fluorescent imaging of mouse lymphatics after injection of the Star 5-60 
conjugate in the hind footpad 1 hour post injection. Arrow: popliteal node, double-arrow: 
iliac node.
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Table 1
IR820 loading degree on the various wt% acid-sugar star polymers (compound 5).
Polymer wt% succination Polymer MW (kDa) wt% IR820 # dyes/polymer
star 5-20 20 54 7.8% 5.3
star 5-40 40 63 6.8% 5.3
star 5-60 60 72 5.2% 4.6
star 5-90 90 85.5 8.6% 9.3
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Table 2
Hydrodynamic Radius and Polydispersity Measurements of sugar star polymers with 0, 20, 40, 60 and 90% wt 
acid modification (Star 5-0, Star 5-20, Star 5-40, Star 5-60, and Star 5-90). Values were reported as mean ± 
standard deviation.
Polymer Hydrodynamic Radius Mean ± Std (nm) Polydispersity Mean ± Std (%)
Star 5-0 12.2 ± 0.8 49.8 ± 12.6
Star 5-20 24.1 ± 2.8 57.1 ± 0.0
Star 5-40 10.8 ± 0.4 57.1 ± 0.0
Star 5-60 13.9 ± 0.3 57.1 ± 0.0
Star 5-90 19.5 ± 4.3 57.1 ± 0.0
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Table 3
IC50 values of the various wt% acid star 3 polymers (compound 3) in various cell lines post 72 h incubation.
Polymer/Cell line Star 3-20 Star 3-40 Star 3-60 Star 3-90
HUVEC ~50 μM (2.7 mg/ml) ~55 μM (3.5 mg/ml) ~100 μM (7.2 mg/ml) ~55 μM (4.7 mg/ml)
A2058 ~50 μM (2.7 mg/ml) ~40 μM (2.5 mg/ml) ~60 μM (4.3 mg/ml) ~50 μM (4.3 mg/ml)
4T1.2 Neu ~50 μM (2.7 mg/ml) ~50 μM (3.2 mg/ml) ~100 μM (7.2 mg/mL) ~55 μM (4.7 mg/ml)
B16F10 ------ ------ >100 μM (7.2 mg/ml) ------
MDA1986 ------ ------ 10 μM (0.72 mg/ml) ------
MDA-MB-231 ------ ------ ≥100 μM (7.2 mg/ml) ------
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Table 4
The tmax and t50% values for the popliteal and iliac lymph nodes after s.c. administration of the star 5 
conjugates (compound 5) in the right hind footpad of mice.
Popliteal Iliac
wt% Acid tmax (h) t50% (h) tmax (h) t50% (h)
star 5-20 0.75-0.83 20 ± 6 1 114 ± 28
star 5-40 0.75-0.83 4.9 ± 0.3 2 19 ± 10
star 5-60 0.75-0.83 1.9 ± 0.6 1 19 ± 6
star 5-90 0.75-0.83 3.4 ± 0.3 0.5 40 ± 16
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